Follow The Filings

RNST Renasant Corporation

Financials, filed as RENASANT CORP (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 exit

In 2026 Q2 Lee Ainslie sold out of Renasant.

Who owns RNST

Sorted by value, long equity only, as of 2026 Q2.

History
Lee Ainslie, Maverick Capital exited 2026 Q2 Last 2026 Q1 0.01% Exit −0.01% 27,863 $1M History

0 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by RNST's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RNST insider trades
  • $70K bought by 1 insider
  • $3.7M sold by 8 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Edward Robinson McGraw Director
    Sale
    $1.5M 35,000 shares at $43.88 14% of stake
    Traded Aug 3 Filed Aug 3
    ↗
  2. Connie L Engel Director
    Sale
    $51K 1,257 shares at $40.90 7.5% of stake
    Traded May 29 Filed Jun 9
    ↗
  3. Albert J Dale III Director
    Sale
    $66K 1,650 shares at $39.80 4% of stake
    Traded May 19 Filed May 21
    ↗
  4. C Mitchell Waycaster Executive Vice Chairman
    Sale
    $502K 12,704 shares at $39.50 6.5% of stake
    Traded May 14 Filed May 15
    ↗
  5. Kelly Hutcheson EVP/Chief Accounting Officer
    Sale
    $52K 1,350 shares at $38.65 7.5% of stake
    Traded Mar 4 Filed Mar 5
    ↗
  6. M Ray Cole Jr. SEVP and Executive Advisor
    Sale
    $813K 20,000 shares at $40.63
    Traded Feb 13 Filed Feb 13
    ↗
  7. Mark Jeanfreau EVP/General Counsel
    Sale
    $227K 6,000 shares at $37.88 8.4% of stake
    Traded Feb 2 Filed Feb 3
    ↗
  8. James C. Mabry IV CFO
    Sale
    $473K 12,500 shares at $37.83 11% of stake
    Traded Jan 30 Filed Feb 2
    ↗
  9. Jonathan A Levy Director
    Buy
    $70K 2,000 shares at $34.79 +24% to stake
    Traded Nov 11, 2025 Filed Nov 12, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 30 stock grants, 9 share withholdings for taxes, 7 sales back to the company, 2 gifts, and 1 option exercise.

Congress

No member of Congress reported trading RNST in the last three years. 1 member listed it in 2025 annual reports.

All Congress trades

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-K/A Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 1.01,2.03,7.01,9.01 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
8-K 5.03,5.07,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income $144.68M $195.46M $181.27M

Balance sheet

Metric FY2023 FY2024 FY2025
Total assets $17.36B $18.03B $26.75B
Total equity $2.3B $2.68B $3.88B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $148.55M $129.43M $271.47M
Cash from investing -$55.4M -$298.04M -$734.02M
Cash from financing $132.2M $459.3M $441.24M
Net change in cash $225.36M $290.68M -$21.31M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Q1 2026

Period archive